The Hsu Lab's vision is to unlock the full potential of multimodal biomedical data, enabling earlier disease detection and more effective treatment. 

We apply state-of-the-art artificial intelligence (AI) and machine learning (ML) algorithms to integrate, analyze, and transform multimodal data, including imaging, genomics, and clinical records, into actionable insights for precision medicine. 

While many of our projects advance AI-driven cancer screening, our broader mission focuses on clinical decision-making in areas of high diagnostic uncertainty, where combining multiple data modalities can significantly enhance patient outcomes. 

Learn about who we are and what we do!